CONMED Corporation (CNMD)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 2,300,020 2,325,680 2,322,720 2,320,120 2,297,590 2,292,040 2,072,260 1,785,720 1,766,020 1,754,090 1,761,970 1,746,610 1,751,670 1,743,130 1,723,910 1,750,970 1,775,100 1,758,420 1,759,400 1,760,840
Total stockholders’ equity US$ in thousands 834,222 796,205 780,194 752,453 745,545 716,337 672,968 789,546 785,435 755,683 744,499 725,570 709,038 683,141 674,898 701,635 710,467 700,922 697,009 693,057
Financial leverage ratio 2.76 2.92 2.98 3.08 3.08 3.20 3.08 2.26 2.25 2.32 2.37 2.41 2.47 2.55 2.55 2.50 2.50 2.51 2.52 2.54

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,300,020K ÷ $834,222K
= 2.76

The financial leverage ratio of Conmed Corp. has been fluctuating over the past eight quarters. It decreased from 3.20 in Q3 2022 to 2.26 in Q1 2022 which indicates a reduction in leverage during that period. Subsequently, the ratio increased steadily to 3.08 in Q4 2022 and remained constant in Q1 2023. However, in the latest quarter, Q4 2023, the financial leverage ratio increased to 2.76.

This trend suggests that Conmed Corp. has been managing its debt levels effectively in the past few quarters but experienced a slight increase in leverage in the most recent period. A financial leverage ratio above 1 indicates that the company relies more on debt financing than equity, and a higher ratio signifies higher financial risk. Thus, a decreasing trend in the leverage ratio is generally seen as positive, while an increasing trend may indicate potential concerns about the company's debt levels and financial risk.


Peer comparison

Dec 31, 2023